The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

Arizona Gold Explorer Finds Extended Mineralization with Two New Holes
Source: Streetwise Reports (11/26/2026)

West Point Gold Corp. (WPG:TSXV; WPGCF:OTCQB) recently announced a management change as well as new assay results, which one newsletter writer notes as "promising."

Striking Gold Again: New Discovery Adds Depth to Ontario's Emerging Camp
Source: Streetwise Reports (11/26/2025)

Dryden Gold Corp. (DRY:TSXV; DRYGF:OTCQB; FSE: X7W) reported high-grade results from its first drill campaign at the Mud Lake target, including 43.10 g/t gold over 0.50 meters. The discovery supports the company's theory of stacked, sub-parallel gold-bearing structures across the Gold Rock Camp.

Barrick-Backed Drill Program Targets Gold Belt Next to One of Africa's Richest Mines
Source: Streetwise Reports (11/26/2025)

Lake Victoria Gold Ltd. (LVG:TSX; LVGLF:OTCQB; E1K:FSE) has reported new third-quarter exploration progress on six Tembo licenses adjacent to Barrick Mining Corp.'s (ABX:TSX; B:NYSE) Bulyanhulu Mine in Tanzania. The company could receive up to US$45 million in contingent payments based on resource discoveries under its agreement with Barrick.

AI Identifies Preclinical Cancer Compounds With Potential to Reach the Brain
Source: Streetwise Reports (11/26/2025)

Rakovina Therapeutics Inc. (RKV:TSX.V) presented new data at the 2025 Society for Neuro-Oncology Annual Meeting on its PARP1-selective inhibitors, with central nervous system penetration. The findings demonstrated how Rakovina's AI-powered discovery platform identified promising drug candidates designed to target brain-involved cancers.

Executive Share Sales Follow Major Cash Milestone at Defense Tech Firm
Source: Streetwise Reports (11/26/2025)

DroneShield Ltd. (DRO:ASX; DRSHF:OTC) disclosed that recent executive share sales were tied to performance options vesting after the company surpassed A$200 million in rolling cash receipts. Management reiterated that the sales did not reflect a change in business outlook.